title: CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.
abstract: OBJECTIVE
  The chemokine CC-ligand 21/secondary lymphoid tissue chemokine (CCL21/SLC) regulates the homing of naïve T cells and dendritic cells that express CC-chemokine receptor 7 (CCR7) from distant sites to lymphoid tissue such as lymph nodes. We hypothesized that CCL21/SLC regulates the migration of CCR7-bearing melanoma cells from a primary lesion to regional tumor-draining lymph nodes.
  
  
  METHODS
  Quantitative real-time reverse transcriptase-PCR (qRT) assay and immunohistochemistry (IHC) were used to assess the level of CCR7 expression in melanoma cell lines and in primary and metastatic melanoma tumors. Cell migration assay using melanoma cell lines was performed under the induction of CCL21/SLC. The CCL21/SLC expression level in tumor-draining sentinel lymph nodes (SLNs) was assessed by both qRT assay and IHC.
  
  
  RESULTS
  Melanoma cell lines and tumors demonstrated heterogeneous expression of CCR7 mRNA by qRT assay. There was strong functional correlation between CCR7 mRNA expression and cell migration induced by CCL21/SLC. IHC evidence of CCR7 expression in primary melanomas significantly (P = 0.02) correlated with Breslow thickness. Assessment of SLN from 55 melanoma patients by qRT assay demonstrated that CCL21/SLC mRNA expression level was significantly (P = 0.008) higher in pathologically melanoma-negative SLNs than in melanoma-positive SLNs.
  
  
  CONCLUSIONS
  This report demonstrates a potential mechanism for recruitment and homing of CCR7(+) metastatic melanoma cells to tumor-draining lymph nodes, which express CCL21/SLC. The study also suggests that lymph nodes bearing metastasis may suppress CCL21/SLC production.
authors.affiliation: Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA.
authors.forename: Hiroya
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Akihide
authors.initials: A
authors.lastname: Fujimoto
authors.forename: Maki
authors.initials: M
authors.lastname: Tanaka
authors.forename: Tomoki
authors.initials: T
authors.lastname: Yamano
authors.forename: Eddy
authors.initials: E
authors.lastname: Hsueh
authors.forename: Dave S B
authors.initials: DS
authors.lastname: Hoon
mesh_terms: D045744:Cell Line, Tumor; D002465:Cell Movement; D054421:Chemokine CCL21; D018925:Chemokines / Q000378:metabolism; D019742:Chemokines, CC / Q000096:biosynthesis*; D017931:DNA Primers / Q000737:chemistry; D003713:Dendritic Cells / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007834:Lasers; D008024:Ligands; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000473:pathology*; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D054400:Receptors, CCR7; D019707:Receptors, Chemokine / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014158:Transcription, Genetic
chemical_list: C515478:CCL21 protein, human; C515370:CCR7 protein, human; D054421:Chemokine CCL21; D018925:Chemokines; D019742:Chemokines, CC; D017931:DNA Primers; D008024:Ligands; D012333:RNA, Messenger; D054400:Receptors, CCR7; D019707:Receptors, Chemokine; D012313:RNA